MC-Actrapid', initiated by a start injection of 1 and 2 mU/kg, respectively) was used. The percent decrease of plasma glucose, FFA and glycerol levels serves as a measure of the whole body sensitivity to exogenous insulin. Under condition of identical steady-state insulin levels the decrease in plasma glucose was significantly reduced in elderly (24 \m=+-\ 5%) vs young (34 \m=+-\ 2%) subjects (P < 0.05). However, a marked sensitivity to the antilipolytic effect of insulin was demonstrated in elderly subjects considered to be resistant to its glucose-lowering action. There was no evidence that disappeared time and metabolic clearance rate of insulin were altered with advancing age. In conclusion, the impaired insulin sensitivity to glucose metabolism seems to be the primary factor responsible for the deterioration of glucose tolerance with advancing age.
It is generally accepted that glucose tolerance de¬ teriorates with advancing age (Nilsson et (Reaven 1977) . Some of the studies have not considered the importance of obesity (Welborn et al. 1969 ) which increases progressively with age (Nilsson et al. 1964; O'Sullivan et al. 1971 ). The total body fat mass is directly related to the degree of glucose intolerance ).
Theoretically, a decrease in glucose tolerance can result from decreased insulin secretion, increased resistance to insulin action or both (Reaven & Olefsky 1977; Ratzmannetal. 1981) . Some authors have suggested a decrease of insulin secretion in elderly persons (Crockford et al. 1966 (Michaelis et al. 1975) . The criteria for the evaluation of glucose tolerance have been described in detail elsewhere (Michaelis et al. 1975; Schulz et al. 1978; Ratzmann et al. 1979 Ratzmann et al. , 1980 (Fig. 1, Table 1 ). In contrast to this there was a deterioration of glucose tolerance in the elderly subjects as demonstrated by significantly higher plasma glucose levels and an increase of the plasma glucose area 60-120 min during the glucose infu¬ sion (Fig. 1, Table 1 ). In the total population group there was a weak direct correlation between age and plasma glucose area 60-120 min (n = 74, r = 0.28; P< 0.05).
The fasting plasma insulin concentration was slightly lower both in the middle-aged and elder group compared with young subjects (Table 1) . The glucose-stimulated insulin levels were signifi¬ cantly reduced at few points in middle-aged and elderly subjects in comparison to the young group (Fig. 1) . Although both the early and late insulin responses were slightly lower in elderly than in young subjects, these differences were not statisti¬ cally significant (Table 1 ). The fasting insulin levels as well as early and late insulin responses showed no significant correlation with advancing age in the total group studied (n = 74, r ranged from -0.21 to-0.04; NS). Table 2 steady-state plasma insulin levels during insulin infusion test were nearly identical in the 3 age-different groups. Simi¬ larly, the metabolic clearance rate and half-dis¬ appearance time of insulin were comparable in young, middle-aged and elderly subjects (Table 2 ).
As demonstrated in
In addition, there was no correlation between increasing age and the metabolic clearance rate during the first and second insulin infusion period in the total group (n = 74, r = 0.03 and 0.06; NS).
Under conditions of identical steady-state insulin levels the decrease in plasma glucose was con- 6.9 ± 3.9
4.4 ± 0.8 sidered as an estimate of insulin sensitivity in vivo.
As shown in (Nilsson et al. 1964; Welborn et al. 1969; Björntorp et al. 1971) and could account for the described differences in the studies. Björntorp et al. (1971) have found higher plasma glucose and insulin responses to an oral glucose challenge in elderly subjects. However, these differences in age-different groups were not apparent when selected young and elderly subjects with comparable body-fat mass and fat-cell dia¬ meters were studied. Similarly, our study revealed that there were no age-dependent changes of insu¬ lin secretion in a selected, body weight matched population with normal fasting plasma glucose concentration, and a negative family history of diabetes, ranging in age from 17 to 65 years.
In order to deal with insulin sensitivity in subjects (Defronzo 1979) . However, the procedure is complicated. To circumvent this methodological problem, we have proposed an insulin infusion technique which per¬ mits to achieve comparable steady-state plasma levels of exogenous insulin . By this approach we could find a direct correlation between the in vivo glucose lowering effect of exogenous insulin and the insulin sensiti¬ vity of adipose tissue in vitro .
As demonstrated by our data there is an agerelated decrease of tissue sensitivity to insulin. The findings are consistent with a previous elegant study of Defronzo (1979) In summary, the present study demonstrates an age-related decline in tissue sensitivity to insulin. Since insulin response to glucose is not significantly altered with advancing age the impaired glucose tolerance in elderly subjects may be primarily due to a decrease in insulin action upon glucose uptake. On the other hand, even a higher sensitivity to the antilipolytic effect of insulin was demonstrated in elderly subjects considered to be résistent to its glucose-lowering action.
